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Abstract
Purpose—To study the effect of maternal psychiatric disorders (depression, anxiety disorder, 
bipolar disease, schizophrenia, unspecified psychiatric disorder, and comorbid conditions) and 
odds of preterm birth.
Methods—The Consortium on Safe Labor (2002-2008), an observational cohort with 12 centers 
from across the U.S. included 223,394 singleton pregnancies with clinical data obtained from 
electronic medical records and maternal diagnoses of psychiatric disorders from maternal 
discharge summaries. Length of gestation was based on the best clinical estimate and categorized 
as birth <39, <37, <34 and <28 weeks’ gestation. The adjusted odds ratios (ORs) with 95% 
confidence intervals of birth were estimated by logistic regression with generalized estimating 
equations.
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Results—Any maternal psychiatric disorder was associated with odds of birth <39 weeks’ 
gestation (OR=1.32, 95% confidence interval 1.28-1.37), <37 weeks’ gestation (OR=1.45, 
1.38-1.52), <34 weeks’ gestation (OR=1.47, 1.35-1.59) and <28 weeks’ gestation (OR=1.57, 
1.36-1.82). Specifically, odds of birth <37 weeks’ gestation were associated with maternal 
depression (OR=1.31, 1.23-1.40), anxiety disorder (OR=1.68, 1.41-2.01), depression with anxiety 
disorder (OR=2.31, 1.93-2.78), bipolar disease (OR=1.54, 1.22-1.94), bipolar disease with 
depression and=or anxiety disorder (OR=1.70, 1.30-2.22) and unspecified psychiatric disorder 
(OR=1.52, 1.41-1.64).
Conclusions—Maternal psychiatric disorders, especially comorbid psychiatric conditions, were 
associated with increased likelihood of preterm birth.
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Introduction
Maternal psychiatric disorders are common among women of childbearing age [1-3]. During 
pregnancy, up to 10% and 13% have depression and anxiety disorder, respectively, while 
3% have bipolar disorder and <1% have psychotic disorders [4,5]. Women with untreated 
psychiatric disorders are less likely to access care, including prenatal care, and may be more 
prone to substance abuse before and during pregnancy [6]. Treatment of maternal 
psychiatric disorders during pregnancy requires consideration, including the severity of the 
maternal condition, the medication to be used and the potential effects of the medication on 
the mother and the fetus [7,8]. While pregnancy is considered a vulnerable period for 
psychiatric disorders, most of the focus in the literature is on the postpartum period [5,9,10].
In 2012, 11.5% of infants in the U.S. were born preterm at <37 weeks’ gestation [11]. 
Preterm neonates are at higher risk of morbidity and mortality as well as increased risk for 
psychiatric disorders later in life [12,13]. Pregnant women with any psychiatric disorder 
have a shorter gestational length [14] and are at increased risk for preterm birth [15-18]. One 
previous study has shown that the associations between preterm birth and maternal 
psychiatric morbidity seemed to be independent of familial relationships and measured 
covariates [19].
However, data on specific psychiatric disorders and preterm birth risk is less consistent. The 
risk of preterm birth has been associated with maternal depression or antidepressant use 
during pregnancy in some [20-24], but not all studies [25-27]. A recent study suggests that 
underlying psychiatric disorders might confound the association between antidepressant use 
and preterm birth, as women who received selective serotonin reuptake inhibitors had lower 
risk of preterm birth than women with psychiatric disorders without exposure to these 
medications [28]. Findings are somewhat less inconsistent between maternal anxiety 
disorders and preterm birth risk [29], whereas maternal schizophrenia and bipolar disease 
are more consistently associated with preterm births [30,31]. The effect of comorbid 
maternal psychiatric disorders is seldom studied.
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In our study from a large, contemporary pregnant U.S. population, we investigated the effect 
of a full range of maternal psychiatric disorders, including comorbid psychiatric conditions, 
on odds of preterm birth.
Methods
The Consortium on Safe Labor (2002-2008, with 87% of births occurring 2005-2007) was 
an observational nationwide U.S. cohort including 12 clinical centers with 19 hospitals, 
chosen due to their geographic distribution and the availability of electronic medical records 
[32]. The study included 228,668 women with 233,844 newborns (including multiples) [32]. 
We excluded 230 deliveries due to errors of identification and all multi-fetal pregnancies 
(N=5,044), rendering a final sample size of 203,999 women with 223,394 singleton 
deliveries. Most women (N=185,422; 90.9%) contributed only one pregnancy. Data on 
maternal demographics, medical, reproductive, and prenatal history, labor and delivery, and 
postpartum data were collected from the hospital delivery admission electronic medical 
records, supplemented with electronic maternal discharge summaries in International 
Classification of Diseases, version 9 (ICD9) codes. The institutional review boards of all 
participating institutions approved the study. Data linkage, cleaning, recording, and 
validation have been previously described, with the medical chart review and the electronic 
data providing good agreement [32].
Exposure data
Data on maternal psychiatric disorders were abstracted from the electronic medical records 
and supplemented with data from the maternal discharge summaries. Women were 
considered to have a psychiatric disorder during pregnancy if they had any of the following 
disorders recorded in the electronic medical record or in the discharge summary:
1. Depression (N=8,354), pregnancies with diagnoses of major depressive disorder (ICD9 
codes 296.2 and 296.3) or depressive disorder not elsewhere classified (ICD9 code 311) 
recorded in the maternal hospital discharge summaries (N=1,437; 17.2%), or pregnancies 
with history of depression recorded in the electronic medical records (N=4,695; 56.2%), or 
pregnancies with both indications of depression (N=2,222; 26.6%). No other specific 
psychiatric disorders recorded in either database.
2. Anxiety (N=689), pregnancies with diagnoses of anxiety state (ICD9 code 300.0) 
recorded in the maternal hospital discharge summaries. No other specific psychiatric 
disorders recorded in either database.
3. Bipolar disorder (N=515), pregnancies with diagnoses of bipolar or manic disorder (ICD9 
codes 296.0, 296.2, or 296.4 to 296.8) recorded in the maternal hospital discharge 
summaries. No other specific psychiatric disorders recorded in either database.
4. Depression with anxiety (N=885), pregnancies with both the aforementioned diagnoses of 
depression and anxiety or pregnancies with diagnoses of dysthymic disorder (ICD9 code 
300.4) recorded in the maternal hospital discharge summaries.
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5. Bipolar disorder with depression and=or anxiety (N=321), pregnancies with the 
aforementioned diagnoses of bipolar disorders and with the diagnoses of depression and=or 
anxiety.
6. Schizophrenia (N=134), women with schizophrenic disorder (ICD-9 code 295) recorded 
in the maternal hospital discharge summaries with=without any other psychiatric disorders.
7. Unspecified psychiatric disorder (N=5,500), pregnancies with diagnoses of psychiatric 
disorders affecting the pregnancy (ICD9 code 648.4) in the maternal hospital discharge 
summaries. No other specific psychiatric disorders were recorded in either database.
Women without these diagnoses were considered to be unexposed (no psychiatric disorder, 
N=206,996, 92.7%). We also evaluated a composite category ‘any psychiatric disorder’ 
(N=16,398; 7.3%) to study the overall effect of psychiatric disorders on preterm birth.
Outcome data
Data on gestational age was derived from the electronic medical records and was based on 
the best obstetrical estimate of gestational length. We explored clinically relevant cut-offs of 
preterm birth: total preterm births at <37 weeks’ gestation, early preterm births at <34 
weeks’ gestation and very early preterm births at <28 weeks’ gestation. We also used a cut-
off of <39 weeks’ gestation given the recent recognition that infants born at 37 and 38 weeks 
have increased neonatal morbidity [33,34]. We also classified the subtype of preterm 
delivery as spontaneous or indicated using a method previously described by our group [35]. 
Spontaneous preterm deliveries included women who presented in preterm labor or with 
premature rupture of the membranes. Indicated preterm deliveries were identified as 
inductions and prelabor cesareans for fetal, maternal or obstetrical indications.
Statistics
Pregnancy was the unit of analysis in all statistical testing. The demographics of the 
population were tabulated using contingency tables. Missing categorical data were included 
in the analyses as their own category. Women with missing continuous data were excluded 
from the analyses.
We used logistic regression with generalized estimating equations to estimate the odds ratios 
(ORs) with 95% confidence intervals (CI) of birth at certain gestational week (<39 vs. ≥39 
weeks’ gestation, <37 vs. ≥37 weeks’ gestation, <34 vs. ≥34 weeks’ gestation, <28 vs. ≥28 
weeks’ gestation) associated with maternal psychiatric disorders. The generalized estimating 
equations with autoregressive correlation matrix accounted for correlation between repeat 
pregnancies within a woman. The analyses were adjusted for maternal age, race=ethnicity, 
prepregnancy body-mass index (kg=m2), insurance and marital status, smoking during 
pregnancy, maternal substance abuse and alcohol use during pregnancy, parity, other 
chronic maternal illnesses (diabetes, chronic hypertension, thyroid diseases, asthma, chronic 
gastrointestinal disorders, chronic cardiovascular diseases and chronic renal diseases) and 
clinical site. We performed additional analyses not adjusting for maternal substance abuse 
and alcohol use during pregnancy, as these factors can be potential mediators in the pathway 
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from maternal psychiatric disorder to preterm birth. As the results were very similar to the 
fully adjusted analyses, we only present the results of the full models.
We also studied the effect of maternal psychiatric disorders on spontaneous and indicated 
preterm births by stratifying the data into three groups: spontaneous births, indicated births 
and births with prelabor cesarean delivery. For the sensitivity analyses, we only included 
women with psychiatric disorders identified via the ICD9 discharge diagnosis codes. All 
analyses were performed with SAS 9.3 (SAS Institute Inc., Cary, North Carolina, US).
Results
Altogether 16,398 of pregnancies (7.3%) were affected by one or more maternal psychiatric 
disorder. Prevalence of individual disorders among pregnant women was: 3.7% depression, 
0.3% anxiety, 0.2% bipolar disorder, 0.1% bipolar disorder with depression and=or anxiety, 
0.1% schizophrenia, and 2.5% unspecified. Women with psychiatric disorders were 
somewhat younger and heavier, and were more often non-Hispanic white and not married. 
They were less likely to have private insurance or to be nulliparous, but were more likely to 
have a chronic disease during pregnancy and to smoke, use alcohol or illicit drugs during 
pregnancy (Table 1).
The distribution of births seemed to be shifted towards earlier gestational weeks among all 
women with psychiatric disorders (Figure 1). Overall, 17.8% and 11.2% of all births were 
preterm <37 weeks’ gestation among women with and without psychiatric disorders during 
pregnancy, respectively. Women with anxiety disorders, bipolar disease and schizophrenia 
had the highest rates of births at <34 weeks’ gestation with 7.6% to 8.2% of births being 
born early preterm, compared to only 3.7% among women without psychiatric disorders 
(Table 1 and Figure 1).
Odds of birth <39 weeks’ gestation were associated with any maternal psychiatric disorder 
and all specific maternal psychiatric disorders (Table 2). Any maternal psychiatric disorder 
was associated with an OR 1.45 (95% CI 1.28-1.37) of preterm birth <37 weeks’ gestation 
(Table 2). When evaluating this association with specific maternal psychiatric disorders, all 
disorders except schizophrenia were associated with increased odds of preterm birth <37 
weeks' gestation. The highest odds of preterm birth were observed among women with 
depression with anxiety disorder (OR 2.31, 95% CI 1.93-2.78), although the confidence 
intervals overlapped with those of other psychiatric disorders (Table 2). Similarly, most 
maternal psychiatric disorders were associated with increased odds of births at <34 and <28 
weeks’ gestation (Table 2). Again, women with depression with anxiety disorder had the 
highest odds of preterm birth <34 weeks (OR 3.06, 95% CI 2.36-3.97) and <28 weeks’ 
gestation (OR 2.99, 95% CI 1.83-4.90) (Table 2).
All results were similar when stratifying the data by preterm delivery subtype indicating that 
psychiatric disorders were associated with an increased risk of both spontaneous and 
indicated preterm delivery, with some loss of precision due to smaller power (data not 
shown). Similar results were also obtained when the exposure groups were restricted to 
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women with psychiatric diagnosis data obtained only via the recorded discharge diagnoses 
(data not shown).
Discussion
In this study from a large contemporary pregnancy cohort from the U.S., we found that all 
maternal psychiatric disorders were associated with increased odds of delivery <39 weeks’ 
gestation, including odds of preterm birth <37, <34 and <28 weeks’ gestation. Maternal 
comorbid psychiatric disorders, especially depression with anxiety seemed to pose the 
highest risks for shorter gestational length and preterm birth, although the odds ratio 
estimates overlapped.
Approximately 7% of women in our study were affected by some psychiatric disorder 
during pregnancy. This prevalence is lower than that of reported in other studies [1-5]. We 
used electronic medical records to identify maternal psychiatric disorders, and as such, we 
may be subject to underreporting of psychiatric disorders compared to studies with interview 
data [36]. Our observed association between psychiatric disorders and preterm birth <37 
weeks' gestation was also smaller than that found in other studies [16,18], also supporting 
the notion of underreporting of psychiatric disorders in our obstetric population. Therefore 
our results can be considered to be conservative.
We observed that all maternal psychiatric disorders were associated with increased odds of 
delivery <39 weeks' gestation, which is a novel finding. This association is clinically 
important given that infants born at 37+0 to 38+7 weeks’ gestation are at higher risk of 
neonatal morbidity than those born 39+0 weeks’ gestation [33,34]. The Eunice Kennedy 
Shriver National Institute of Child Health and Human Development now suggests defining 
term births as 39+0 to 40+6 weeks’ gestation [37]. Children born <37 weeks' gestation have 
been found to have more psychiatric symptoms and diagnoses later in life [12,13], but it is 
unclear if such intergenerational effects are also observed with children born at 37+0 to 
38+7 weeks’ gestation.
Additionally, we observed that any maternal psychiatric disorder was associated with 
preterm birth <37, <34 and <28 weeks’ gestation. Anxiety, bipolar disease, depression with 
anxiety disorder and unspecified psychiatric disorder were statistically significantly 
associated with preterm birth <37, <34 and <28 weeks’ gestation, whereas depression was 
significantly only associated preterm birth <37 and <34 weeks’ gestation. Interestingly, 
maternal schizophrenia was not associated with increased odds of preterm birth <37 weeks’ 
gestation in our study, but we acknowledge that the numbers in the schizophrenia group are 
small.
Previous studies have associated maternal depression and=or selective serotonin reuptake 
inhibitor use to increased risk of preterm birth [20-24], but contradictory findings have also 
been reported [25-27]. A more recent study found a protective effect between preterm birth 
and exposure to selective serotonin reuptake inhibitors when exposed women were 
compared to women with psychiatric diagnoses without medication exposure [28]. In that 
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study, women with psychiatric diagnoses without medication had higher odds of preterm 
birth when compared to healthy women [28], a finding similar to our study.
A novel finding in our study was the observed association between comorbid maternal 
psychiatric disorders and preterm birth. Our results indicate that especially anxiety disorders 
were associated with preterm birth or birth <39 weeks' gestation, which is consistent with 
the results of a recent meta-analysis of prospective cohort studies [41], and an earlier review 
[42]. Historically more attention may be given to depression clinically, especially during the 
postpartum period when suicidality or postpartum psychosis may be a concern. The 
American College of Obstetricians and Gynecologists has not yet made a firm 
recommendation to screen for depression or anxiety disorders during or after pregnancy, 
though depression is common and has been incorporated into the care of high risk women 
[40]. Although depression and anxiety disorder share some symptoms and may coexist, 
stress reactions are thought to be higher among women with anxiety disorders [38]. 
Maternal stress, on the other hand, has been associated with preterm birth via behavioral or 
inflammation mediated mechanisms [39]. Whether stress reactions explain the observed 
association between preterm birth and maternal anxiety disorders need further studies.
We observed an association between both spontaneous and indicated preterm delivery and 
maternal psychiatric disorders. This was most pronounced for earlier gestational ages (<34 
and <28 weeks’ gestation). There are several potential mechanisms through which maternal 
psychiatric disorders may associate with shorter gestational length. Women with psychiatric 
disorders have been shown to be less likely to access prenatal care and are more likely to 
smoke or use alcohol or illicit drugs during pregnancy [4-6]. The latter was also observed in 
our data, although we may be subject to underreporting of substance abuse compared to 
other studies and interview data [17,36]. However, we assume that the most severe cases of 
substance abuse are reported in the pregnancy-related medical records and most women are 
truly non-users. A previous report has shown minimal bias in relation to misclassification of 
substance abuse when most of the population are truly non-users [43]. Our observed 
association between maternal psychiatric disorders and preterm birth remained even after 
adjusting for substance abuse. However, as some women with psychiatric disorders may 
alleviate their symptoms via substance abuse, the relationship between maternal psychiatric 
disorders, substance abuse and shorter gestational length may be more complex than our 
statistical model assumes. This too merits further studies.
Women with psychiatric disorders were also more likely to have other chronic diseases, 
which could elevate preterm birth risk, but accounting for chronic disease did not change the 
observed findings. The observed association between increased odds of preterm birth was 
also not fully explained by increased risk of pregnancy complications such as preeclampsia 
as the odds of preterm birth were similar in women with maternal psychiatric disorders with 
spontaneous and indicated preterm birth. There is also evidence that suggests the 
pharmacological treatment itself for depression may be associated with preterm delivery 
[44], although this association is confounded by indication in that women with more severe 
disease are more likely to be treated [28]. Our study did not collect information on 
psychiatric medication use, and we cannot therefore evaluate the effect of treatment on the 
odds of preterm birth among women with psychiatric disorders.
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Our study was based on a large and contemporary cohort of pregnancies across the U.S., 
allowing us to capture pregnancies of women from all social class and racial=ethnic groups. 
In our study the prevalence of maternal psychiatric disorders during pregnancy was 
relatively low. Our large sample size allowed us to observe an association between increased 
odds of early birth associated with the understudied maternal disorders of bipolar disease 
and schizophrenia. We believe our findings are generalizable to the broader population, 
particularly those whose disease was severe enough to be recorded in their medical record. 
However, our study is limited to data recorded in the medical record, including the lack of 
medication data.
In summary, deliveries complicated by maternal psychiatric disorders, particularly when 
complicated by anxiety disorders, were associated with an increased risk of both 
spontaneous and indicated preterm delivery. This is most worrisome for earlier gestational 
ages less than 34 and 28 weeks. These findings have important public health implications 
given that 7.3% of women in our study had a psychiatric diagnosis recorded in their medical 
record or discharge summary.
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Figure 1. 
The prevalence of birth at different gestational weeks by maternal psychiatric disorders.
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Table 1
The demographic characteristics of pregnancies with and without maternal psychiatric disorders, the 
Consortium on Safe Labor (2002-2008).
Demographics
No 
psychiatric
disorders
(N=206,996;
92.7%)
Any 
psychiatric
disorder
(N=16,398;
7.3%)
Depression
(N=8,354;
3.7%)
Anxiety
(N=689;
0.3%)
Bipolar
disorder
(N=515;
0.2%)
Depression
with
anxiety
(N=885;
0.4%)
Bipolar
disorder
with
depression
and/or
anxiety
(N=321;
0.1%)
Unspecified
psychiatric
disorder
(N=5,500; 
2.5%)
Schizophrenia
(N=134;
0.1%)
Maternal age
in years
<20 18,945 (9.2) 1,751 (10.7) 796 (9.5) 39 (5.7) 91 (17.7) 47 (5.3) 37 (11.5) 727 (13.2) 14 (10.5)
≥20 but <25 51,930 (25.1) 4,659 (28.4) 1,993 (23.9) 156 (22.6) 154 (29.9) 200 (22.6) 115 (35.8) 2,009 (36.5) 32 (23.8)
≥25 but <30 57,759 (27.9) 4,455 (27.2) 2,384 (28.5) 208 (30.2) 143 (27.8) 259 (29.3) 80 (24.9) 1,357 (24.7) 24 (17.9)
≥30 but <35 46,924 (22.7) 3,226 (19.7) 1,900 (22.7) 162 (23.5) 77 (15.0) 221 (25.0) 61 (19.0) 776 (14.1) 29 (21.6)
>35 31,161 (15.1) 2,277 (13.9) 1,260 (15.1) 123 (17.9) 50 (9.7) 153 (17.3) 28 (8.7) 628 (11.4) 35 (26.1)
Unknown 277 (0.1) 30 (0.2) 21 (0.3) 1 (0.3) 0 5 (1.6) 0 3 (1.0) 0
Number of
pregnancies
1 189,082 (91.3) 14,917 (91.0) 7,470 (89.4) 649 (94.2) 478 (92.8) 770 (87.0) 272 (84.7) 5,158 (93.8) 120 (89.6)
2 17,073 (8.3) 1,375 (8.4) 811 (9.7) 40 (5.8) 35 (6.8) 104 (11.8) 46 (14.3) 326 (5.9) 13 (9.7)
≥3 841 (0.4) 106 (0.6) 73 (0.9) 0 2 (0.4) 11 (1.2) 3 (0.9) 16 (0.3) 1 (0.8)
Race/ethnicity
Non-Hispanic
white
99,944 (48.3) 10,504 (64.1) 5,408 (64.7) 533 (77.4) 366 (71.1) 692 (78.2) 218 (67.9) 3,255 (59.2) 32 (23.9)
Non-Hispanic
black
46,790 (22.6) 3,448 (21.0) 1,366 (16.4) 71 (10.3) 111 (21.6) 74 (8.4) 63 (19.6) 1,680 (30.6) 83 (61.9)
Hispanic 37,337 (18.0) 1,702 (10.4) 1,156 (13.8) 49 (7.1) 24 (4.7) 75 (8.5) 28 (8.7) 356 (6.5) 14 (10.5)
Asian/Pacific
Islander
9,091 (4.4) 116 (0.7) 59 (0.7) 11 (1.6) 5 (1.0) 3 (0.3) 1 (0.3) 35 (0.6) 2 (1.5)
Other 5,089 (2.5) 206 (1.3) 109 (1.3) 3 (0.4) 4 (0.8) 5 (0.6) 2 (0.6) 83 (1.5) 0
Unknown 8,745 (4.2) 422 (2.6) 256 (3.1) 22 (3.2) 5 (1.0) 36 (4.1) 9 (2.8) 91 (1.7) 3 (2.2)
Marital status
Married 124,563 (60.2) 6,616 (40.4) 4,206 (50.4) 420 (61.0) 157 (30.5) 476 (53.8) 93 (29.0) 1,239 (22.5) 25 (18.7)
Single 72,954 (35.2) 8,504 (51.9) 3,530 (42.3) 213 (30.9) 319 (61.9) 330 (37.3) 194 (60.4) 3,829 (69.6) 89 (66.4)
Other 2.829 (1.4) 713 (4.4) 309 (3.7) 30 (4.4) 33 (6.4) 32 (3.6) 24 (7.5) 269 (4.9) 16 (11.9)
Unknown 6,650 (3.2) 565 (3.5) 309 (3.7) 26 (3.8) 6 (1.2) 47 (5.3) 10 (3.1) 163 (3.0) 4 (3.0)
Insurance
status
Private 117,618 (56.8) 7.296 (44.5) 4,701 (56.3) 423 (61.4) 160 (31.1) 591 (66.8) 97 (30.2) 1,309 (23.8) 15 (11.2)
Public 63,827 (30.8) 8,325 (50.8) 3,323 (39.8) 231 (33.5) 332 (64.5) 281 (31.8) 210 (65.4) 3,847 (70.0) 101 (75.4)
Self-pay 2,405 (1.2) 258 (1.6) 116 (1.4) 4 (0.6) 1 (0.2) 1 (0.1) 6 (1.9) 127 (2.3) 3 (2.2)
Other 289 (0.1) 30 (0.2) 12 (0.1) 1 (0.2) 1 (0.2) 0 3 (0.9) 10 (0.2) 3 (2.2)
Unknown 22,857 (11.0) 489 (3.0) 202 (2.4) 30 (4.4) 21 (4.1) 12 (1.4) 5 (1.6) 207 (3.8) 12 (9.0)
Pre-pregnancy
body mass
index, kg/m2
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Demographics
No 
psychiatric
disorders
(N=206,996;
92.7%)
Any 
psychiatric
disorder
(N=16,398;
7.3%)
Depression
(N=8,354;
3.7%)
Anxiety
(N=689;
0.3%)
Bipolar
disorder
(N=515;
0.2%)
Depression
with
anxiety
(N=885;
0.4%)
Bipolar
disorder
with
depression
and/or
anxiety
(N=321;
0.1%)
Unspecified
psychiatric
disorder
(N=5,500; 
2.5%)
Schizophrenia
(N=134;
0.1%)
≥25 81,717 (39.5) 5,352 (32.6) 2,689 (32.2) 233 (33.8) 143 (27.8) 251 (28.4) 91 (28.4) 1,913 (34.8) 32 (23.9)
≥25 but <30 30,975 (15.0) 2,501 (15.3) 1,382 (16.5) 106 (15.4) 70 (13.6) 118 (13.3) 40 (12.5) 762 (13.9) 23 (17.2)
≥30 but <35 14,391 (7.0) 1,381 (8.4) 792 (9.5) 45 (6.5) 49 (9.5) 61 (6.9) 22 (6.9) 401 (7.3) 11 (8.2)
≥35 10,807 (5.2) 1,345 (8.2) 814 (9.7) 43 (6.2) 45 (8.7) 55 (6.2) 30 (9.4) 345 (6.3) 13 (9.7)
Unknown 69,106 (33.4) 5,819 (35.5) 2,677 (32.0) 262 (38.0) 208 (40.4) 400 (45.2) 138 (43.0) 2,079 (37.8) 55 (41.0)
Nulliparous
Maternal risk
factors during
pregnancy
83,685 (40.4) 5,349 (32.6) 2,583 (30.9) 269 (39.0) 223 (43.3) 332 (37.5) 119 (37.1) 1,781 (32.4) 42 (31.3)
Chronic disease 5,900 (2.9) 703 (4.3) 468 (5.6) 34 (4.9) 27 (5.2) 49 (5.5) 14 (4.4) 106 (1.9) 5 (3.7)
Alcohol use 3,154 (1.5) 936 (5.7) 323 (3.9) 26 (3.8) 42 (8.2) 31 (3.5) 25 (7.8) 482 (8.9) 7 (5.2)
Smoking 10,317 (5.0) 4,614 (28.1) 1,490 (17.8) 84 (12.2) 116 (22.5) 160 (18.1) 105 (32.7) 2,617 (47.6) 42 (31.3)
Illicit drug use 2,572 (1.2) 1,592 (9.7) 489 (5.9) 28 (4.1) 63 (12.2) 39 (4.4) 56 (17.5) 890 (16.2) 27 (20.2)
Gestational 
age
at birth, weeks
≥39 122,468 (59.2) 8,212 (50.1) 4,227 (50.6) 442 (49.9) 254 (49.3) 301 (43.7) 148 (46.1) 2,787 (50.7) 53 (39.6)
≥37 but <39 61,315 (29.6) 5,269 (32.1) 2,826 (33.8) 288 (32.5) 165 (32.0) 234 (34.0) 102 (31.8) 1.602 (29.1) 52 (38.8)
≥34 but <37 15,485 (7.5) 1,878 (11.5) 899 (10.8) 88 (9.9) 53 (10.3) 88 (12.8) 47 (14.6) 685 (12.5) 18 (13.4)
≥28 but <34 5,642 (2.7) 759 (4.6) 306 (3.7) 51 (5.8) 33 (6.4) 49 (7.1) 18 (5.6) 295 (5.4) 7 (5.2)
<28 2,086 (1.0) 280 (1.7) 96 (1.2) 16 (1.8) 10 (1.9) 17 (2.5) 6 (1.9) 131 (2.4) 4 (3.0)
Delivery
characteristics
Spontaneous
labor
111,171 (53.7) 9,213 (56.2) 4.625 (55.4) 335 (48.6) 267 (51.8) 469 (53.0) 157 (48.9) 3,289 (59.8) 71 (53.0)
Induced labor 72,064 (34.8) 5,089 (31.0) 2,700 (32.3) 255 (37.0) 174 (33.8) 278 (31.4) 113 (35.2) 1,535 (27.9) 34 (25.4)
Prelabor section 23,761 (11.5) 2,096 (12.8) 1,029 (12.3) 99 (14.4) 74 (14.4) 138 (15.6) 51 (15.9) 676 (12.3) 29 (21.6)
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Table 2
The odds of birth at certain gestational age, by maternal psychiatric disorders.
Exposure
Birth <39 vs. ≥39 
weeks’
gestation
OR (95% CI)
Birth <37 vs. ≥37 
weeks’
gestation
OR (95% CI)
Birth <34 vs. ≥34 
weeks’
gestation
OR (95% CI)
Birth <28 vs. ≥28 
weeks’
gestation
OR (95% CI)
Any psychiatric disorder 1.32 (1.28-1.37) 1.45 (1.38-1.52) 1.47 (1.36-1.59) 1.57 (1.36-1.82)
Depression 1.32 (1.26-1.38) 1.31 (1.23-1.40) 1.18 (1.05-1.31) 1.18 (0.95-1.47)
Anxiety 1.46 (1.28-1.67) 1.68 (1.41-2.01) 2.20 (1.70-2.84) 2.36 (1.42-3.91)
Bipolar disease 1.40 (1.17-1.67) 1.54 (1.22-1.94) 2.15 (1.54-3.00) 1.90 (1.01-3.60)
Depression with anxiety 1.79 (1.54-2.09) 2.31 (1.93-2.78) 3.06 (2.36-3.97) 2.99 (1.83-4.90)
Bipolar disease with depression
and/or anxiety 1.47 (1.17-1.83) 1.70 (1.30-2.22) 1.51 (0.99-2.31) 1.50 (0.66-3.43)
Unspecified psychiatric disorder 1.22 (1.15-1.30) 1.52 (1.41-1.64) 1.60 (1.42-1.80) 1.83 (1.49-2.26)
Schizophrenia 1.57 (1.08-2.27) 1.15 (0.73-1.80) 1.09 (0.55-2.16) 1.33 (0.47-3.76)
The odds are estimated using logistic regression with generalized estimating equations, adjusting for maternal age, body-mass index (calculated as 
weight/height2 in kg/m2), insurance status, marital status, smoking during pregnancy, substance abuse and alcohol use during pregnancy, parity, 
other chronic maternal illnesses and clinical site.
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